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All data in the bottom row of Table II should have been shifted one column to the right. The corrected table appears below.
Table II.  Mutations in VH3-23-Cγ transcripts from PBL from ATRD patients and controlsa
Clones Mutations in V region Clustering ratio R/S
Age (yr) All Distinct Unmutated Total % bp CDR/FRb CDRs FRs
ATRD patients
 ATRD1 25 15 13 0 302 8.6 0.73 3.4 1.8
 ATRD2 13 15 14 2 258 6.8 0.73 3.7 1.7
 ATRD3 15 6 6 0 194 11.9 0.62 3.9 2.0
 Total 36 33 2 754 8.4 0.70 3.6 1.8
Controls
 C1 14 12 11 1 100 3.4 1.22 5.9 1.5
 C2 adult 11 11 0 275 9.3 0.73 4.5 1.7
 C3 28 6 6 0 147 9.0 0.69 5.7 2.0
 C4 24 8 8 0 178 8.2 0.51 14.0 2.2
 C5 30 4 4 0 49 4.5 0.53 c 1.1
 Total 41 40 1 749 6.9 0.70 6.2 1.8
aTotal RNA was prepared from PBL from all the patients and controls, except for donor C2; buffycoat was obtained and CD27 positive B cells were used.
bFR, framework region.
cToo few mutations to give a reliable ratio.